Floxogril-O 500 Tablet is a combination antibiotic medication containing Ofloxacin 200mg and Ornidazole 500mg, designed to treat a wide range of bacterial and protozoal infections. Ofloxacin, a fluoroquinolone antibiotic, works by inhibiting bacterial DNA gyrase, thereby preventing bacterial replication and growth. Ornidazole, a nitroimidazole derivative, is effective against anaerobic bacteria and protozoa by disrupting their DNA synthesis. This dual-action formulation is commonly prescribed for infections such as urinary tract infections, gastrointestinal infections, respiratory tract infections, skin and soft tissue infections, and certain sexually transmitted infections. Floxogril-O 500 is particularly useful in mixed infections where both aerobic and anaerobic pathogens are involved. The tablet should be taken as directed by a healthcare professional, usually with food to minimize gastrointestinal discomfort. Patients should complete the full prescribed course to prevent antibiotic resistance and ensure effective eradication of the infection. It is contraindicated in individuals with hypersensitivity to fluoroquinolones or nitroimidazoles, and caution is advised in patients with liver or kidney impairment. Potential side effects include nausea, dizziness, headache, and gastrointestinal disturbances. Consultation with a healthcare provider is essential before starting therapy to ensure safety and efficacy.